The Impact of Initial Gefitinib or Erlotinib Versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-0357
Full Text
Open PDFAbstract
Available in full text
Date
June 25, 2012
Authors
Publisher
American Association for Cancer Research (AACR)